Abstract:Abstract Background Melatonin is an amine hormone with high content in gastrointestinal tract, which plays a positive role in anti-inflammatory. Intestinal microbiota imbalance and intestinal immune damage caused by colitis are often accompanied by a decrease in endogenous melatonin. However, whether melatonin supplementation improves colitis, and the mechanism is unclear. Methods The study focused on melatonin treatment of colitis in dextran sodium sulfate(DSS)-fed mice and analyzed the mechanism multidimensionally by quantitative real-time PCR, western blotting, immunofluorescence, 16s-rDNA, and mRNA-seq. Results The weight, colon length, and microscopic structure of the colonic crypts were improved in DSS-fed mice after melatonin supplementation. Tumor necrosis factor-α(TNF-α), interleukin-1β(IL-1β), and IL-6 were significantly elevated in colon tissues of the DSS group, and this result was down-regulated in the melatonin group. Tight junction proteins(ZO-1 and occludin) in the colonic mucosa were significantly decreased in the DSS group, and improved in the melatonin group. In terms of antimicrobial peptides, melatonin supplementation significantly increased levels of defa-3, defa-4, and CRAMP. Surprisingly, our study found increased expression of SIRT1 protein in the intestinal tissues of the melatonin group. After the addition of Ex-527, a SIRT1 inhibitor, the protective effect of melatonin on DDS-fed mice disappeared, and tight junction proteins did not differ from those of the DSS group. In addition, fecal 16s-rRNA results in the control, DSS, and melatonin groups suggested some differences. The DSS group had an increase in α-diversity (Shannon's Diversity Index) and a decrease in β-diversity (PCoA) in comparison to the control group, and all of these changes were reversed in the melatonin group, but there was no significance between the three groups. At the phylum level, Firmicutes were significantly increased in the DSS-fed group, and the melatonin group reversed this change. At the genus level, the abundance of Akkermansia was decreased in the DSS group and increased with melatonin supplementation. While the abundance of Desulfovibrio, a pathogenic genus was increased in the DSS group and decreased with melatonin supplementation. Colon tissue mRNA-seq identified a number of possible pathogenic and therapeutic pathways, such as Slc7a2, a cationic amino acid transporter. Conclusion The study suggests that melatonin modulates the intestinal mucosal barrier through the SIRT1 pathway to alleviate colitis.

S2938 A Rare Case of Melatonin Induced Microscopic Colitis

Collagenous colitis and lymphocytic colitis: Patient characteristics and clinical presentation

P1139 Lymphocytic Colitis: A large case series in the United Kingdom

Melatonin controls microbiota in colitis by goblet cell differentiation and antimicrobial peptide production through Toll-like receptor 4 signalling

Microscopic colitis: Common cause of unexplained nonbloody diarrhea

Intraepithelial and Lamina Propria Lymphocytes Do Not Correlate With Symptoms or Exposures in Microscopic Colitis

Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care

Melatonin-Mediated Colonic Microbiota Metabolite Butyrate Prevents Acute Sleep Deprivation-Induced Colitis in Mice

S3943 Colliding Microscopic Colitis: A Case of Mixed Lymphocytic Colitis and Incomplete Collagenous Colitis

S371 Incidence of Microscopic Colitis: A 10-Year Systematic Review of Population-Based Studies

Chronic Diarrhea Owing to Microscopic Colitis: A Cohort Study with Insights into Diagnostic Challenges and Size of the Problem

S1482 Investigating the Natural Progression of Microscopic Colitis: Analysis of the Loyola University Microscopic Colitis Registry (LUMiCoR)

Melatonin Protects Against Colistin-Induced Intestinal Inflammation and Microbiota Dysbiosis

DOP44 Melatonin Ameliorates Colitis In DSS-fed Mice Via The SIRT1 Pathway

Melatonin Mitigates Oxazolone-Induced Colitis in Microbiota-Dependent Manner

The Role of Aeromonas-Goblet Cell Interactions in Melatonin-Mediated Improvements in Sleep Deprivation-Induced Colitis

Lymphocytic colitis associated with entacapone

Melatonin Attenuates Dextran Sodium Sulfate Induced Colitis in Obese Mice

Colonoscopic Resolution of Melanosis Coli After Cessation of Senna Laxative Use

Mechanism of Action of Melatonin as a Potential Adjuvant Therapy in Inflammatory Bowel Disease and Colorectal Cancer

Melanosis Coli Is Not Associated with Colonic Dysmotility Nor Severity of Pediatric Functional Constipation